๐Ÿ”ฌresearch

AOD-9604 vs Semaglutide: Fat Loss Mechanism Comparison

AOD-9604 vs Semaglutide

AOD-9604 and semaglutide both appear in fat metabolism research but work through completely different mechanisms. This comparison helps researchers understand the differences when configuring protocol tracking in Dosed.

โš ๏ธ

Important Disclaimer

Semaglutide is an FDA-approved prescription medication (as Ozempic/Wegovy). AOD-9604 is NOT FDA-approved. Dosed tracks both but does not provide medical advice. Follow healthcare provider instructions for prescription medications.

Comparison Table

Feature
AOD-9604
Semaglutide
Type
HGH fragment (aa 176-191)
GLP-1 receptor agonist
FDA Approved
No
Yes (Ozempic, Wegovy)
Mechanism
Lipolytic via modified HGH fragment
GLP-1 receptor agonism (appetite + metabolism)
Administration
Subcutaneous injection (daily)
Subcutaneous injection (weekly)
Dosing Frequency
Once daily
Once weekly
Reconstitution
Required
Pre-filled pen (Rx) or reconstitution (research)
Research Status
Limited clinical data
Extensive Phase 3 data
Dosed Tracking
Daily schedule + reconstitution
Weekly schedule + titration

Key Differences

  • โ†’Semaglutide is FDA-approved with extensive clinical trial data; AOD-9604 is a research compound
  • โ†’Completely different mechanisms: AOD-9604 acts via HGH fragment pathway; semaglutide via GLP-1
  • โ†’AOD-9604 requires daily injection; semaglutide is once weekly
  • โ†’Semaglutide has well-documented appetite suppression; AOD-9604 research is more limited
  • โ†’AOD-9604 always requires reconstitution; prescription semaglutide comes in pre-filled pens

Tracking Considerations

  • โ€ขAOD-9604: daily subcutaneous scheduling with reconstitution calculator
  • โ€ขSemaglutide: weekly scheduling with dose titration tracking
  • โ€ขBoth use injection site rotation โ€” Dosed's body map supports both protocols
  • โ€ขIf tracking prescription semaglutide, use Dosed alongside healthcare provider guidance

Dosed App Features

  • โœ“Daily or weekly scheduling based on compound
  • โœ“Reconstitution calculator for AOD-9604
  • โœ“Dose titration tracking for semaglutide
  • โœ“Injection site rotation for both protocols

Quick Reference

  • ๐Ÿ’กThese compounds work through completely different biological mechanisms
  • ๐Ÿ’กSemaglutide has decades of GLP-1 research behind it; AOD-9604 research is more limited
  • ๐Ÿ’กSome researchers study both compounds โ€” Dosed supports multi-compound protocols
  • ๐Ÿ’กAlways differentiate between FDA-approved medications and research compounds

Track Your Protocol

Set up reminders, track your doses, and maintain your protocol history with Dosed.

Download Dosed

FAQs

Common questions about this comparison

They are not interchangeable. Semaglutide is an FDA-approved medication with extensive clinical data. AOD-9604 is a research compound with limited clinical evidence. They work through completely different mechanisms.

Yes. Dosed supports unlimited compound tracking. You would set up AOD-9604 as a daily protocol and semaglutide as a weekly protocol, each with their own tracking parameters.

More Comparisons